Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 76.08%
March 31, 2026 70.08%
December 31, 2025 68.23%
September 30, 2025 65.18%
June 30, 2025 55.54%
March 31, 2025 56.04%
December 31, 2024 58.35%
September 30, 2024 69.96%
June 30, 2024 67.18%
March 31, 2024 64.14%
December 31, 2023 54.41%
September 30, 2023 57.26%
June 30, 2023 55.28%
March 31, 2023 58.43%
December 31, 2022 56.90%
September 30, 2022 60.97%
June 30, 2022 48.03%
March 31, 2022 57.22%
December 31, 2021 54.45%
September 30, 2021 60.44%
June 30, 2021 60.25%
March 31, 2021 50.36%
December 31, 2020 56.12%
September 30, 2020 46.11%
June 30, 2020 64.36%
Date Value
March 31, 2020 51.17%
December 31, 2019 50.77%
September 30, 2019 56.87%
June 30, 2019 50.21%
March 31, 2019 49.63%
December 31, 2018 34.36%
September 30, 2018 32.87%
June 30, 2018 20.84%
March 31, 2018 13.11%
December 31, 2017 -2.41%
September 30, 2017 18.29%
June 30, 2017 28.70%
March 31, 2017 42.95%
December 31, 2016 29.49%
September 30, 2016 37.48%
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015 0.00%
December 31, 2014 0.00%
September 30, 2014 0.00%
June 30, 2014
March 31, 2014 0.00%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
GlucoTrack, Inc. --
Abbott Laboratories 57.05%
AngioDynamics, Inc. 56.00%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%

Gross Profit Margin (Quarterly) Related Metrics